Debiopharm Innovation Fund

Useful insights from start-up founders, CEOs and experienced investors Learn about the main success factors of this exciting stage of entrepreneurship Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial… Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence Fosanis Expands to Assist Cancer Patients in Great Britain BC platforms announces $20m growth financing to underpin position as Europe’s leading RWD provider

Support companies like yours

Your technologies and business models aim to make drug development and treatment more patient centric, accessible and affordable? We seek startups like yours that improve the cancer patient journey and re-imagine how clinical trials are conducted

We are also interested in digital health companies focused on bacterial infections

In the area of disruptive therapeutic platforms, we invest in solutions focused on gene and cell therapies

You will have access to our expertise situated at the crossroads of technological solutions and pharmaceutical know-how which include: Drug development, Regulatory processes, Reimbursement and market access, Management of health-tech companies

With the aim to

• Increase the pace of your scale-up process with strategic guidance and piloting,
• Provide long-term, evergreen funding with multiple financing rounds,
• Work along with your team to achieve a positive return on investment for all stakeholders,
• Drive our portfolio investments towards successful exits

Our track record for your entrepreneurial success

• Lead investor in 19 out of 25 last investment rounds
• USD 120 million invested since 2008
• Portfolio companies have achieved 10 FDA clearances, 13 CE marks & 2 IPOs and 4 trade exits Discover the people who guide and bring long-term vision to the digital health investments at Debiopharm Discover how we can help you take your ambition to the next level